{
    "2019-08-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "Schall Law Firm",
                        "Investigating Claims",
                        "Novartis AG",
                        "Losses"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Roche's Tecentriq Combo Gets EU Nod for Critical Breast Cancer",
                "features": {
                    "keywords": [
                        "Roche",
                        "Tecentriq",
                        "EU Nod",
                        "Breast Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "EQUITY ALERT: Rosen Law Firm Continues To Investigate Securities Claims Against Novartis AG â€“ NVS",
                "features": {
                    "keywords": [
                        "Rosen Law Firm",
                        "Securities Claims",
                        "Novartis AG"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Forget Pfizer, Add These Big Drugmakers to Your Portfolio",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Drugmakers",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}